Transfusion-associated graft-versus-host disease in ataxia telangiectasia [6]

Lancet

Volumn 349, Issue 9046, 1997, Pages 179-

  Watson, H G ^a   McLaren, K M ^b   Todd, A ^b   Wallace, W H ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ATAXIA TELANGIECTASIA; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BONE MARROW DEPRESSION; CASE REPORT; CELLULAR IMMUNODEFICIENCY; DIARRHEA; DRUG MEGADOSE; FEVER; GRAFT VERSUS HOST REACTION; HEPATITIS; HUMAN; LETTER; MALE; PANCYTOPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH;

EID: 0342601884     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60980-4     Document Type: Article

References (5)

1. Sazama K, Holland PV. Transfusion-induced graft-versus host disease. In: Garratty G, editor. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1993.
2. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med 1990; 323: 315-21.
3. Williamson LM. BCSH Blood Transfusion Task Force: guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfus Med 1996; 6: 261-71.
4. Appleton AR, Sviland A, Pearson ADJ, Wilkes J, Green MA, Malcolm AJ. Diagnostic features of transfusion associated graft-versus-host disease. J Clin Pathol 1994; 47: 541-46.
5. Greenbaum BH. Transfusion-associated graft-versus-host disease: Historical perspectives, incidence and current use of irradiated blood products. J Clin Oncol 1991; 9: 1889-902.